Skip to main content

Table 5 Appendix I. Complementary data of urine (Figure 1, f-2; Table 2a) and plasma (Table 2b). For other informations see there

From: Idiopathic recurrent calcium urolithiasis (IRCU): pathophysiology evaluated in light of oxidative metabolism, without and with variation of several biomarkers in fasting urine and plasma - a comparison of stone-free and -bearing male patients, emphasizing mineral, acid-base, blood pressure and protein status

  

Urine

       

Plasma

    

Code

Markers Strata

HX μM

XA μM

UA μM

Ox μM

Cit mM

Na mM

K mM

Mg mM

Mg mM-1 -1

Ox

μM-1 -1

AVP pg ml -1

Osmalarity mOsm-1 -1

1, 25(OH) 2D pg-ml -1

A

P-UA

             
 

L

12.4(0.9)[29]

7.3(0.6)[29]

378(12)

24(3)

0.31(0.02)

13(1)

8(0.3)

0.28(0.01)

0.85(0.01)

1.74(0, 08)[25]

4, 7(0.5)[26]

294(1, 2)[26]

52(2)[74J

 

H

11.3(0.7)[34]

5.4(0.6)[34]

404(18)

21(1)

0.27(0.01)

12(1)

8(0.3)

0.14(0, 01)

0, 85(0, 01)

1.63(0.10)127]

4.8(0.5)abbrgrp>31

296(0.3)]29]

56(2)[72]

 

P

0.15

0.005 d

0.12

0.18

0.04

0.1

0.12

0.02

0.32

0.19

0.43

0.08

0.13

B

U-MDA

             
 

L

12.1(0.9)[27]

5.9(0.7)[27]

351(13)

24(3)

0, 26(0, 01)

11(1)

7(0.3)

0.24(0.01)

0.85(0, 00;

1.69(0.11)[22J

5.6(0.6)[24]

296(1.2)[25]

54(2)[76]

 

H

11.7(0.7)[36]

6.6(0.5)[36]

430(16)

21(1)

0.31(0.01)

14(1)

9(0.3)

0.27(0.01)

0.86(0.01;

1.69(0.08)[301

4.2(0.3)[33]

295(1.0)f30]

54(2)[70]

 

P

0, 32

0.2]

< 0.001

0.18

0.009

0.001

0.001

0.04

0.04

0.49

0.01

0.28

0.40

C

U-MDA/P-UA

             
 

L

11.0(0.7)[31]

4.9(0, 5)[31]

361(13)

24(3)

0.26(0.01)

11(1)

7(0.3)

0.23(0.01)

0.84(0.00)

1.56(0.08)[24]

5.0(0.6)[27]

296(1.1)[27]

53(2)[74]

 

H

12, 6(0, 9)[32]

7.7(0, 6)[32]

421(17)

21(1)

0, 32(0.02)

15(1)

9(0.3)

0.29(0.01)

0.86(0.01)

1.79(0.09)[28]

4.2(0.3)[30]

295(1.1)[28]

55(2)[72]

 

P

0.09

< 0.001

0.002

0.16

0.001

0.001

0.001

0.001

0.02

0.04

0.02

0.19

0.17

D

U-NIT

             
 

L

11, 4(0.9)[18]

6.4(0.8)[18]

374(15)

26(4)

0.29(0.02)

12(1)

7(0.4)

0.24(0.01)

0.85(0.01)

1.65(0.11)[19]

5.0(0.8)[17]

293(1.4)[20]

56(3)[57]

 

II

12.2(0.8)[271

6.7(0.6)[27]

404(22)

21(1)

0.30(0.02)

13(1)

8(0.4)

0.28(0.02)

0.86(0.01)

1, 65(0, 09)[27]

4.6(0.4)[25]

297(0.9)[25]

53(2)[55]

 

P

0.26

0.38

0.13

0.04

0.34

0.07

0.02

0.02

0.2

0, 49

0.3

0.02

0.21

E

U-NIT/P-UA

             
 

L

11.2(0.9)[17]

5.5(0.9)[17]

384(22)

26(4)

0.29(0.02)

12(1)

12(0.7)

0.23(0, 01)

0.85(0.01)

1.47(0.09)[18]

4.8(0.7)[17]

294(1, 6)[19]

55(3)[57]

 

H

I2.3(().8)abbrgrp>28

7.2(0.6)[281

394(19)

21(1)

0.29(0.02)

13(1)

8(0.4)

0.29(0.02)

0.86(0.01)

1, 77(0, 09)[28]

4.7(0.5)[25]

296(0.8)126]

53(2)[55]

 

P

0.2

0.05

0, 35

0.04

0.37

0.1

0.19

0.005

0.1

0.02

0.43

0.19

0.31

  1. Shaded areas: parameters supposedly participating in IRCU pathogenesis (see also APP III).